Article Cited by others

ORIGINAL ARTICLE

PSCA, Cox-2, and Ki-67 are independent, predictive markers of biochemical recurrence in clinically localized prostate cancer: a retrospective study

Kim Sung Han, Park Weon Seo, Park Bo Ram, Joo Jungnam, Joung Jae Young, Seo Ho Kyung, Chung Jinsoo, Lee Kang Hyun

Year : 2017| Volume: 19| Issue : 4 | Page no: 458-462

   This article has been cited by
 
1 Prognostic Significance of Serum PSA Level and Telomerase, VEGF and GLUT-1 Protein Expression for the Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy
Anna Gasinska,Janusz Jaszczynski,Urszula Rychlik,Elzbieta Luczynska,Marek Pogodzinski,Mikolaj Palaczynski
Pathology & Oncology Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
2 The Role of Immunohistochemical Analysis as a Tool for the Diagnosis, Prognostic Evaluation and Treatment of Prostate Cancer: A Systematic Review of the Literature
Arie Carneiro,Álan Roger Gomes Barbosa,Lucas Seiti Takemura,Paulo Priante Kayano,Natasha Kouvaleski Saviano Moran,Carolina Ko Chen,Marcelo Langer Wroclawski,Gustavo Caserta Lemos,Isabela Werneck da Cunha,Marcos Takeo Obara,Marcos Tobias-Machado,Adam G. Sowalsky,Bianca Bianco
Frontiers in Oncology. 2018; 8
[Pubmed]  [Google Scholar] [DOI]
3 Apparent diffusion coefficients in prostate cancer: correlation with molecular markers Ki-67, HIF-1a and VEGF
Teng Ma,Shaolin Yang,Haiyan Jing,Lin Cong,Zhixin Cao,Zhiling Liu,Zhaoqin Huang
NMR in Biomedicine. 2018; : e3884
[Pubmed]  [Google Scholar] [DOI]
4 Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy
Priscilla Léon,Geraldine Cancel-Tassin,Sara Drouin,Marie Audouin,Justine Varinot,Eva Comperat,Xavier Cathelineau,François Rozet,Christophe Vaessens,Steven Stone,Julia Reid,Zaina Sangale,Patrick Korman,Morgan Rouprêt,Gaelle Fromond-Hankard,Olivier Cussenot
World Journal of Urology. 2018;
[Pubmed]  [Google Scholar] [DOI]
5 Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis
C-J Ko,S-W Lan,Y-C Lu,T-S Cheng,P-F Lai,C-H Tsai,T-W Hsu,H-Y Lin,H-Y Shyu,S-R Wu,H-H Lin,P-W Hsiao,C-H Chen,H-P Huang,M-S Lee
Oncogene. 2017; 36(32): 4597
[Pubmed]  [Google Scholar] [DOI]

 

Read this article